65,437 trials
Mucopolysaccharidosis VI
Primary: 12-Minute Walk Test — 187; 118 meters
Attention Deficit Hyperactivity Disorder
Primary: Dermal Reactions — 46; 97; 151; 6 Participants
Rhinitis, Allergic, Seasonal · Rhinitis, Allergic, Perennial
Primary: The Change From Baseline in the 12-hour AM/PM-PRIOR (Reflective) Total 5 Symptom Score (T5SS) From Subject Daily Diaries Averaged Over Treatment Days 1 to 15 — -3.01…
Plasmodium Falciparum Malaria
Primary: Occurrence of Solicited Systemic Symptoms During a 7-day Surveillance Period (Systematically Collected) Following Vaccinations at Days 0, 30, and 60. — 0; 0; 0; 0…
Neuralgia, Postherpetic
Primary: Mean Pain Scores at Endpoint — 5.12; 4.81; 4.26; 4.49 score on scale — p=0.262
Bipolar Disorder
Primary: Number of Participants Who Had a Mood Relapse. — 42; 76; 98; 59 Participants — p=<0.001
Chronic Obstructive Pulmonary Disease · Bronchitis · Emphysema
Primary: Percent (%) of Participants With Adverse Events (AEs), in Particular COPD Exacerbations — 66.7; 67.8; 76.2; 10.9 percent of participants
Osteoporosis
Primary: Change From Baseline at 18 Month Endpoint in Lumbar Spine Bone Mineral Density (BMD) — 0.059; 0.028 grams per square centimeters — p=<0.001
Mucopolysaccharidosis I · Hurler Syndrome · Hurler-Scheie Syndrome
Primary: Safety Evaluation — 3; 0; 0; 1 participants
Overactive Bladder
Primary: Mean Number of Micturition Episodes Per 24 Hours — 12.7; 9.7 number of episodes — p=<0.0001
Hypertension
Primary: Change in Mean Sitting Systolic Blood Pressure (MSSBP) — 159.7; 159.0; 131.2; 137.5 mm Hg
Type 2 Diabetes Mellitus
Primary: Urinary 11-Dehydrothromboxane B2 (11-dTxB2) — 525.3; 540.8; 585.3; 625.1 pg/mg creatinine
Stroke
Primary: Percentage of Participants With Revascularization of the Occluded Target Vessel — 81.2 Percentage of Participants
Stents · Coronary Artery Disease · Total Coronary Occlusion
Primary: Primary Endpoint: In-segment Late Loss (LL) — 0.14; 0.28 millimeters — p=<0.0001
Obesity, Morbid
Primary: Percent of Subjects Who Had Adverse Events With the Swedish Adjustable Gastric Band (SAGB) — 69.6 Percent of Subjects